Coloplast leverer i Q2 lidt højere vækst i EBIT-driftsoverskud end forventet af analytikere
12/5 08:13
Consensus estimater Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and Interventional Urology, challenging quarter in Wound & Tissue Repair. Reported revenue in DKK grew 2%, with 4%-points negative impact from currencies. Return on invested capital after tax before special items was 15%. Organic growth […]...